Objective: To study the effect of a new fermented milk product containing GABA (FMG) on the blood pressure (BP) of patients with mild hypertension.
Design: A randomized, placebo-controlled, single-blind trial.
Setting: The study was carried out at the outpatient clinic of the Cardiovascular Disease Center, Tokyo Metropolitan Police Hospital, Japan.
Subjects: The study population comprised 39 mildly hypertensive patients (16 women and 23 men) aged 28–81 y (mean, 54.2 y).
Interventions: The study consisted of a 12-week period of daily intake of FMG or placebo (weeks 1–12) followed by 2 weeks of no intake (weeks 13 and 14). We measured the peripheral BP and heart rate of seated patients at weeks 0, 2, 4, 8, 12 and 14. Routine blood study and urinalysis were performed before and after the intake.
Results: There was a significant decrease of BP within 2 or 4 weeks, and it remained decreased throughout the 12-week intake period. For the FMG recipients, the mean decrease after 12 weeks was 17.4±4.3 mmHg in the systolic BP (SBP) and 7.2±5.7 mmHg in the diastolic BP (DBP). Both of these values differed statistically from baseline levels (P<0.01), and the SBP of the FMG group differed from the placebo group (P<0.05). Heart rate, body weight, hematological and blood chemistry variables, and urinalysis results (glucosuria and proteinuria) did not vary both groups throughout the study.
Conclusions: FMG may contribute to lowering BP in mildly hypertensive people.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
BMC Genomics Open Access 16 March 2022
Transcriptomics reveal different metabolic strategies for acid resistance and gamma-aminobutyric acid (GABA) production in select Levilactobacillus brevis strains
Microbial Cell Factories Open Access 06 September 2021
Subscribe to Journal
Get full journal access for 1 year
only $9.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Billingsley, M & Suria, A (1982). Effects of peripherally administered GABA and other amino acids on cardiopulmonary responses in anesthetized rats and dogs. Arch. Int. Pharmacodyn., 255, 131–140.
Elliott, KAC & Hobbiger, F (1959). Gamma aminobutyric acid: circulatory and respiratory effects in different species: re-investigation of the anti-strychnine action in mice. J. Physiol., 146, 70–84.
Erdö, SL & Wolff, JR (1990). γ-Aminobutyric acid outside the mammalian brain. J. Neurochem., 54, 363–372.
Giuliani, S, Maggi, AC & Meli, A (1986). Differences in cardiovascular responses to peripherally administered GABA as influenced by basal conditions and type of anaesthesia. Br. J Pharmac., 88, 659–670.
Guidelines Subcommittee of WHO/ISH (1999). 1999 World Health Organization—International Society of Hypertension guide-lines for the management of hypertension. J. Hypertens., 17, 165–166.
Hayakawa, K, Kimura, M & Kamata, K (2002). Mechanism underlying gamma-aminobutyric acid-induced antihypertensive effect in spontaneously hypertensive rats. Eur. J. Pharmac., 438, 107–113.
Jorde, R & Bønaa, KH (2000). Calcium from dairy products, vitamin D intake, and blood pressure: the Tromsø study. Am. J. Clin. Nutr., 71, 1530–1535.
Kawano, Y, Matsuoka, H, Takishita, S & Omae, T (1998). Effects of magnesium supplementation in hypertensive patients: assessment by office, home, and ambulatory blood pressures. Hypertension, 32, 260–265.
Kawase, M, Hashimoto, H, Hosoda, M, Morita, H & Hosono, A (2000). Effect of administration of fermented milk containing whey protein concentrate to rats and healthy men on serum lipids. J. Dairy Sci., 83, 255–263.
Kuriyama, K & Sze, Y (1971). Blood–brain barrier to H3-γ-aminobutyric acid in normal and amino oxyacetic acid-treated animals. Neuropharmacology, 10, 103–108.
Miller, GD, DiRienzo, DD, Reusser, ME & MacCarron, DA (2000). Benefits of dairy product consumption on blood pressure in humans: a summary of the biomedical literature. J. Am. Coll. Nutr., 19, 147S–164S.
Ministry of Health, Labor, Welfare in Japan (1989). Guideline for the Clinical Evaluation of Antihypertensive Drugs, p488(in Japanese)
Nakamura, Y, Yamamoto, N, Sakai, K, Okubo, A, Yamazaki, S & Takano, T (1995). Purification and characterization of angiotensin I-converting enzyme inhibitor from sour milk. J. Dairy Sci., 78, 777–783.
Nicol, RA, Malenka, RC & Kauer, JA (1990). Functional comparison of neurotransmitter receptor subtypes in mammalian central nervous system. Physiol. Rev., 70, 513–565.
Onoda, A, Saikusa, T, Horino, T, Kajimoto, A, Miyamoto, A, Tanaka, Y, Murakami, T, Okada, & Murai, H (1998). Accumulative effects of γ-aminobutyric acid (GABA) from defatted rice germ. The First International Symposium on Disease Prevention by IP6 and Other Rice Components, p97
Oomori, S, Yano, T, Okamoto, J, Tushida, F, Murai, T & Higuchi, M (1987). Effect of anaerobically treated tea (Gabaron tea) on the blood pressure of spontaneously hypertensive rats. Nippon Nôgeikagaku Kaishi, 61, 1449–1451, (abstract in English)
Pawlowska, M, Chen, S & Armstrong, D (1993). Enantiomeric separation of fluorescent, 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate-tagged amino acids. J. Chromatogr., 641, 257–265.
Research Group of γ-Aminobutyric Acid in Tokyo (1960). Clinical aspects on the use of gamma-aminobutyric acid. In:Inhibition in the Nervous System and Gamma-aminobutyric Acid. Proceedings of an International Symposium, City of Hope Medical Center, Duarte, California, 22–24 May, 1959, pp579–581, Oxford: Pergamon Press
Stanton, HC (1963). Mode of action of gamma aminobutyric acid on the cardiovascular system. Arch. Int. Pharmacodyn., 143, 195–204.
Takahashi, H, Tiba, M, Iino, M & Takayasu, T (1955). The effect of γ-aminobutyric acid on blood pressure. Jpn. J. Physiol., 5, 334–341.
Tanaka, C (1985). γ-Aminobutyric acid in peripheral tissues. Life Sci., 37, 2221–2235.
Tsuji, K, Ichikawa, T, Tanabe, N, Abe, S, Tarui, S & Nakagawa, Y (1992). Antihypertensive activities of Beni-Koji extracts and γ-aminobutyric acid in spontaneously hypertensive rats. Jpn. J. Nutr., 50, 285–291, (abstract in English)
Van Gelder, MN & Elliott, KAC (1958). Disposition of γ-aminobutyric acid administered to mammals. J. Neurochem., 3, 139–143.
Yamamoto, N, Maeno, M & Takano, T (1999). Purification and characterization of an antihypertensive peptide from a yogurt-like product fermented by Lactobacillus helveticus CPN4. J. Dairy Sci., 82, 1388–1393.
We thank Mr Y Suzuki and his coworkers (Development Division, Yakult Honsha Co. Ltd, Japan) for preparing the fermented milk and placebo products.
About this article
Cite this article
Inoue, K., Shirai, T., Ochiai, H. et al. Blood-pressure-lowering effect of a novel fermented milk containing γ-aminobutyric acid (GABA) in mild hypertensives. Eur J Clin Nutr 57, 490–495 (2003). https://doi.org/10.1038/sj.ejcn.1601555
- γ-aminobutyric acid (GABA)
- blood pressure
- fermented milk
This article is cited by
Molecular Breeding (2023)
BMC Genomics (2022)
Improve gamma-aminobutyric acid production in Corynebacterium glutamicum by optimizing the metabolic flux
Systems Microbiology and Biomanufacturing (2022)
GABA production and probiotic addition in Saccharina angustata (Hidakakombu) by fermentation of Lactiplantibacillus pentosus SN001
Fisheries Science (2022)
GABA as a signalling molecule: Possible mechanism for its enhanced commercial production by cyanobacteria
Journal of Applied Phycology (2022)